Humbi AI by Innovaccer Publishes Landmark JAMA Study on Telepsychiatry's Impact on Medicaid Outcomes

In partnership with Frontier Psychiatry, the study reveals lower hospitalization rates and stable costs for telepsychiatry patients—validating the role of data-driven insights in value-based mental health care.

Humbi AI by Innovaccer, the industry's leading actuarial intelligence platform, today announced its research publication in JAMA Network focusing on "Medicaid Costs and Patient Outcomes Associated with Outpatient Telepsychiatry Clinics." This landmark study, co-researched with Frontier Psychiatry, a telepsychiatry clinic in Billings, Montana, represents Humbi AI's first research based on clinical data, showcasing its expertise in healthcare data access and analytics.

The cross-sectional study leveraged Humbi AI’s national Medicaid analytics platform to analyze 5,372 Montana Medicaid patients, comparing 2,686 patients who received services from Frontier Psychiatry, with an equal number of propensity-matched controls who did not use Frontier's services during the study period. The comprehensive analysis revealed significant improvements in key healthcare metrics. Key findings include:

  • Patients using telepsychiatry services had a 38.0% lower annualized hospitalization rate compared to controls (274.3 vs. 442.6 hospitalizations per 1,000 patients)
  • Telepsychiatry patients had 17.9% lower rate of admissions from emergency departments (47.7% vs. 58.1% of hospitalizations)
  • Overall monthly costs to Medicaid were statistically similar between the groups ($685.50 for Frontier patients vs. $734.00 for non-Frontier patients per member per month) across all cost categories analyzed
  • While professional service costs were higher for telepsychiatry patients, inpatient hospitalization costs were significantly lower

These findings provide strong evidence that additional investment in outpatient telepsychiatry services is warranted across healthcare systems.

"The best decisions in healthcare are backed by solid evidence," said Abhinav Shashank, Co-founder and CEO of Innovaccer. "And the evidence here is compelling, telepsychiatry keeps more people out of hospitals without adding costs. Since bringing Humbi AI into our family, we've been focused on delivering exactly these kinds of practical insights that help providers succeed in value-based care."

Humbi AI's platform provides healthcare organizations with actuarially grounded insights into cost, utilization, and risk trends across specialties and regions. This intelligence enables providers to benchmark performance and negotiate smarter contracts, allows payers to design more sustainable reimbursement models, and helps life sciences companies align market strategies with areas of high cost or opportunity.